1. Home
  2. SXC vs YDES Comparison

SXC vs YDES Comparison

Compare SXC & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SunCoke Energy Inc.

SXC

SunCoke Energy Inc.

HOLD

Current Price

$6.54

Market Cap

555.4M

Sector

Industrials

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$6.98

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SXC
YDES
Founded
1960
2013
Country
United States
Taiwan
Employees
2477
N/A
Industry
Steel/Iron Ore
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
555.4M
543.0M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
SXC
YDES
Price
$6.54
$6.98
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
1.8M
19.2K
Earning Date
04-29-2026
04-30-2026
Dividend Yield
7.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,600,300,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.30
N/A
52 Week Low
$5.52
$5.40
52 Week High
$9.82
$25.00

Technical Indicators

Market Signals
Indicator
SXC
YDES
Relative Strength Index (RSI) 52.98 45.61
Support Level $6.24 N/A
Resistance Level $6.90 $9.11
Average True Range (ATR) 0.28 0.87
MACD 0.09 0.18
Stochastic Oscillator 79.02 60.24

Price Performance

Historical Comparison
SXC
YDES

About SXC SunCoke Energy Inc.

SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: